Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,688 | 101,577 | 157,651 | 25,521 | 23,735 |
| Marketable Securities | 217,255 | 181,574 | 117,292 | 117,427 | 131,172 |
| Receivables | 4,931 | 3,501 | 2,938 | 2,263 | 1,636 |
| Inventories | 973 | 312 | 332 | 154 | 167 |
| TOTAL | $265,443 | $288,552 | $278,933 | $145,824 | $157,492 |
| Non-Current Assets | |||||
| PPE Net | 8,395 | 6,553 | 4,982 | 4,947 | 4,263 |
| Intangibles | 17,435 | 19,783 | 22,130 | 24,477 | 26,825 |
| Other Non-Current Assets | 12,477 | 8,346 | 7,443 | 1,179 | 1,531 |
| TOTAL | $38,307 | $34,682 | $34,555 | $30,603 | $32,619 |
| Total Assets | $303,750 | $323,233 | $313,488 | $176,427 | $190,111 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,051 | N/A | 1,317 | 1,410 | 1,628 |
| Accounts payable and accrued liabilities | 1,206 | 597 | 505 | 1,171 | 1,113 |
| Accrued Expenses | 11,521 | 14,283 | 9,340 | 6,086 | 8,367 |
| TOTAL | $15,301 | $16,285 | $11,161 | $8,667 | $11,108 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,521 | 147 | 581 | 824 | 1,060 |
| Deferred Revenues | 523 | 1,405 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 175,000 | 175,000 | 150,000 | 0 | 0 |
| TOTAL | $178,892 | $175,147 | $150,581 | $824 | $1,060 |
| Total Liabilities | $194,193 | $191,431 | $161,742 | $9,490 | $12,168 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 3 | 3 | N/A |
| Common Shares | 399,649 | 388,963 | 388,109 | 387,269 | 386,895 |
| Retained earnings | -290,552 | -259,065 | -237,725 | -221,859 | -210,279 |
| Other shareholders' equity | 460 | 1,904 | 1,363 | 1,527 | 1,327 |
| TOTAL | $109,557 | $131,802 | $151,747 | $166,937 | $177,943 |
| Total Liabilities And Equity | $303,750 | $323,233 | $313,488 | $176,427 | $190,111 |